Pfizer Inc. (NYSE: PFE) Tuesday reported a decline in first-quarter earnings and revenues. However, the results exceeded analysts’ forecast.
Earnings, on an adjusted basis, dropped to $0.80 per share from $0.85 per share in the first quarter of 2019. The pharma company reported unadjusted profit of $3.4 billion or $0.61 per share for the three-month period, down from last year’s $3.88 billion or $0.68 per share. Earnings, meanwhile, came in above the estimates.
The weakens in the bottom-line performance is attributable to a 8% decline in revenues to $12 billion. Analysts were looking for a slightly lower number.
Shares of Pfizer closed the last trading session higher and continued to gain during Tuesday’s pre-market session. The stock has declined 7% in the past twelve months.
The massive slowdown in the IPO market continued in the second half as the challenges posed by high inflation and interest rate hikes weighed on investor confidence. Meanwhile, there is
The automotive sector is one of the worst affected by the combination of high inflation and rising interest rates. Consumers have become more cautious and are prioritizing their purchases with
The IPO market has witnessed muted activity this year, and things don’t seem to have improved in the second half. The upcoming public listing of video game technology firm Ultimax